What should you know about valneva chikungunya vaccine?

Chikungunya is spread by infected mosquitoes and can cause fever, joint pain, muscle aches, rash, and fatigue. A vaccine prepares the immune system to recognise the virus, but it does not treat an infection that has already started and does not replace mosquito-bite prevention. Suitability depends on factors such as age, health history, travel plans, pregnancy status, immune function, and local recommendations. Product availability and authorised use can vary by location.

Discuss the vaccine with a GP or travel-health clinician well before travel or possible exposure. Bring your medication list and mention allergies, immune conditions, pregnancy or breastfeeding, and any previous vaccine reaction. Ask when protection is expected, whether another dose is advised, and which bite-avoidance measures remain necessary. After vaccination, mild fever, headache, muscle aches, or soreness may occur; follow the advice given at the appointment.

Seek urgent help for trouble breathing, swelling of the face or throat, widespread hives, fainting, or severe weakness after vaccination. Contact a clinician for a high or persistent fever, worsening joint pain, or symptoms that concern you. If fever or joint pain develops after mosquito exposure or travel, assessment is useful because vaccination does not rule out infection.

Is this vaccine appropriate for my travel or exposure risk? Does my medical history affect the decision? What timing and follow-up apply? How should I respond if fever or joint pain develops afterward?